Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasmin Hisham

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Immunology Research|January 10, 2019
Identification of Cross-Protective Potential Antigens against Pathogenic <i>Brucella</i> spp. through Combining Pan-Genome Analysis with Reverse VaccinologyYasmin Hisham, Yaqoub Ashhab
Viruses|April 30, 2021
Identification of Highly Conserved SARS-CoV-2 Antigenic Epitopes with Wide Coverage Using Reverse Vaccinology ApproachYasmin Hisham, Yaqoub Ashhab, Sang-Hyun Hwang, et al.
Immune Network|November 19, 2021
SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of <i>Spike</i> GeneHyunjhung Jhun, Ho-Young Park, Yasmin Hisham, et al.
Biomedicines|July 27, 2022
Interleukin-18 Binding Protein in Immune Regulation and Autoimmune DiseasesSeung Yong Park, Yasmin Hisham, Hyun Mu Shin, et al.
Nucleic Acids Research|October 31, 2025
connectomeDB2025: a rigorously curated, multi-species resource of experimentally supported ligand-receptor interactionsPeiwen Liu, Sakura Eri B Maezono, Weitao Lin, et al.
Cancer Control : Journal of the Moffitt Cancer Center|September 29, 2023
Associations Between Serum Soluble Toll-like Receptors 4 and 9 and Breast Cancer in Egyptian PatientsInas Moaz, Fayrouz A Fouad, Hossam Elmasry, et al.
Frontiers in Immunology|March 14, 2022
Comparison of the Seven Interleukin-32 Isoforms' Biological Activities: IL-32θ Possesses the Most Dominant Biological ActivitySaerok Shim, Siyoung Lee, Yasmin Hisham, et al.
Frontiers in Immunology|March 14, 2022
A Paradoxical Effect of Interleukin-32 Isoforms on CancerSaerok Shim, Siyoung Lee, Yasmin Hisham, et al.
Frontiers in Immunology|March 20, 2023
COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2Yasmin Hisham, Sun-Min Seo, Sinae Kim, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Immunology Research|January 10, 2019
Identification of Cross-Protective Potential Antigens against Pathogenic <i>Brucella</i> spp. through Combining Pan-Genome Analysis with Reverse VaccinologyYasmin Hisham, Yaqoub Ashhab
Viruses|April 30, 2021
Identification of Highly Conserved SARS-CoV-2 Antigenic Epitopes with Wide Coverage Using Reverse Vaccinology ApproachYasmin Hisham, Yaqoub Ashhab, Sang-Hyun Hwang, et al.
Immune Network|November 19, 2021
SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of <i>Spike</i> GeneHyunjhung Jhun, Ho-Young Park, Yasmin Hisham, et al.
Biomedicines|July 27, 2022
Interleukin-18 Binding Protein in Immune Regulation and Autoimmune DiseasesSeung Yong Park, Yasmin Hisham, Hyun Mu Shin, et al.
Nucleic Acids Research|October 31, 2025
connectomeDB2025: a rigorously curated, multi-species resource of experimentally supported ligand-receptor interactionsPeiwen Liu, Sakura Eri B Maezono, Weitao Lin, et al.
Cancer Control : Journal of the Moffitt Cancer Center|September 29, 2023
Associations Between Serum Soluble Toll-like Receptors 4 and 9 and Breast Cancer in Egyptian PatientsInas Moaz, Fayrouz A Fouad, Hossam Elmasry, et al.
Frontiers in Immunology|March 14, 2022
Comparison of the Seven Interleukin-32 Isoforms' Biological Activities: IL-32θ Possesses the Most Dominant Biological ActivitySaerok Shim, Siyoung Lee, Yasmin Hisham, et al.
Frontiers in Immunology|March 14, 2022
A Paradoxical Effect of Interleukin-32 Isoforms on CancerSaerok Shim, Siyoung Lee, Yasmin Hisham, et al.
Frontiers in Immunology|March 20, 2023
COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2Yasmin Hisham, Sun-Min Seo, Sinae Kim, et al.
Pageof 1